XML 35 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Revenues:    
Product revenues, net $ 375,375  
Royalty revenues 38,981 6,061
Collaborative revenues 24,381 67,601
Total revenues 438,737 73,662
Costs and expenses:    
Cost of product revenues 25,918  
Royalty expenses 13,293 2,666
Research and development expenses 196,371 158,612
Sales, general and administrative expenses 111,146 71,523
Restructuring expense 360 760
Total costs and expenses 347,088 233,561
Income (loss) from operations 91,649 (159,899)
Interest income 364 1,402
Interest expense (4,105) (12,001)
Change in fair value of derivative instruments   (5,598)
Income (loss) before provision for income taxes 87,908 (176,096)
Provision for income taxes 32  
Net income (loss) 87,876 (176,096)
Net loss attributable to noncontrolling interest (Alios) (3,714)  
Net income (loss) attributable to Vertex $ 91,590 $ (176,096)
Net income (loss) per share attributable to Vertex common shareholders:    
Basic (in dollars per share) $ 0.44 $ (0.87)
Diluted (in dollars per share) $ 0.43 $ (0.87)
Shares used in per share calculations:    
Basic (in shares) 208,018 202,329
Diluted (in shares) 219,264 202,329